Yaron Werber
Stock Analyst at TD Cowen
(4.96)
# 106
Out of 4,587 analysts
757
Total ratings
60.7%
Success rate
28%
Average return
Main Sectors:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintained: Buy | $94 | $53.23 | +76.59% | 43 | Jul 29, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,146 | $865.25 | +32.45% | 55 | Jul 28, 2026 | |
| FBRX Forte Biosciences | Downgraded: Hold | $77 | $76.52 | +0.63% | 9 | Jul 27, 2026 | |
| GMAB Genmab | Upgraded: Buy | $32 → $43 | $28.44 | +51.20% | 25 | Jul 22, 2026 | |
| KLRA Kailera Therapeutics | Maintained: Buy | $57 | $16.73 | +240.71% | 4 | Jul 7, 2026 | |
| RLAY Relay Therapeutics | Reiterated: Buy | n/a | $19.33 | - | 18 | Jun 18, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | n/a | $108.33 | - | 11 | Jun 12, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $424 | $320.48 | +32.30% | 44 | Jun 2, 2026 | |
| NUVB Nuvation Bio | Reiterated: Buy | n/a | $6.62 | - | 19 | Jun 1, 2026 | |
| AMGN Amgen | Maintained: Buy | $420 → $326 | $384.70 | -15.18% | 71 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $227 | $255.64 | -11.32% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 → $29 | $33.84 | -13.45% | 25 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.6292 | - | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 → $29 | $18.94 | +53.12% | 19 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.15 | - | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.50 | - | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.09 | - | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $35.09 | - | 7 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $22.45 | - | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $37.66 | - | 14 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $325 | $247.80 | +31.15% | 27 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.64 | - | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $29.42 | - | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.65 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $51 → $55 | $55.34 | -0.61% | 34 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $25.21 | +94.37% | 43 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 | $92.55 | +1.57% | 28 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.50 | - | 6 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | - | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.15 | - | 11 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $323.04 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €664.00 | €752.20 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1,891.50 | n/a | 1 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.19 | n/a | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $52.20 | n/a | 1 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $3 | $6.85 | n/a | 6 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.17 | n/a | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $684 → $565 | $717.39 | n/a | 30 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.28 | n/a | 1 | Dec 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.17 | n/a | 10 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.74 | n/a | 6 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.49 | n/a | 6 | Dec 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $40.36 | n/a | 4 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $497 → $345 | $206.75 | n/a | 16 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 → $110 | $129.86 | n/a | 13 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $266 → $94 | $7.77 | n/a | 5 | Sep 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $137 → $132 | $33.33 | n/a | 2 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 | $7.99 | n/a | 1 | Nov 10, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $15.34 | n/a | 3 | Apr 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $37.68 | n/a | 5 | Jun 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $100 | $474.41 | n/a | 7 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $0.0001 | n/a | 1 | Mar 12, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $52.06 | n/a | 1 | Nov 17, 2010 |
Ionis Pharmaceuticals
Jul 29, 2026
Maintained: Buy
Price Target: $94
Current: $53.23
Upside: +76.59%
argenx SE
Jul 28, 2026
Maintained: Buy
Price Target: $1,146
Current: $865.25
Upside: +32.45%
Forte Biosciences
Jul 27, 2026
Downgraded: Hold
Price Target: $77
Current: $76.52
Upside: +0.63%
Genmab
Jul 22, 2026
Upgraded: Buy
Price Target: $32 → $43
Current: $28.44
Upside: +51.20%
Kailera Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $57
Current: $16.73
Upside: +240.71%
Relay Therapeutics
Jun 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.33
Upside: -
Dianthus Therapeutics
Jun 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $108.33
Upside: -
BeOne Medicines AG
Jun 2, 2026
Reiterated: Buy
Price Target: $424
Current: $320.48
Upside: +32.30%
Nuvation Bio
Jun 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.62
Upside: -
Amgen
May 18, 2026
Maintained: Buy
Price Target: $420 → $326
Current: $384.70
Upside: -15.18%
May 18, 2026
Maintained: Buy
Price Target: $227
Current: $255.64
Upside: -11.32%
May 18, 2026
Rated: Buy
Price Target: $38 → $29
Current: $33.84
Upside: -13.45%
May 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.6292
Upside: -
May 13, 2026
Rated: Hold
Price Target: $21 → $29
Current: $18.94
Upside: +53.12%
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $20.15
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $6.50
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $1.09
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $35.09
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $22.45
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $37.66
Upside: -
May 7, 2026
Maintained: Buy
Price Target: $325
Current: $247.80
Upside: +31.15%
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $1.64
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $29.42
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $4.65
Upside: -
May 5, 2026
Rated: Buy
Price Target: $51 → $55
Current: $55.34
Upside: -0.61%
May 5, 2026
Maintained: Buy
Price Target: $49
Current: $25.21
Upside: +94.37%
May 5, 2026
Maintained: Hold
Price Target: $94
Current: $92.55
Upside: +1.57%
Apr 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.50
Upside: -
Mar 31, 2026
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: -
Mar 26, 2026
Maintained: Buy
Price Target: n/a
Current: $2.15
Upside: -
May 21, 2025
Reiterated: Buy
Price Target: $230
Current: $323.04
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: €664.00
Current: €752.20
Upside: n/a
Apr 3, 2024
Maintained: Hold
Price Target: n/a
Current: $1,891.50
Upside: n/a
Mar 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.19
Upside: n/a
Mar 11, 2024
Maintained: Buy
Price Target: n/a
Current: $52.20
Upside: n/a
Jun 26, 2023
Maintained: Hold
Price Target: $25 → $3
Current: $6.85
Upside: n/a
Nov 1, 2022
Downgraded: Hold
Price Target: n/a
Current: $7.17
Upside: n/a
Feb 8, 2021
Maintained: Hold
Price Target: $684 → $565
Current: $717.39
Upside: n/a
Dec 14, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $11.28
Upside: n/a
Aug 5, 2020
Maintained: Buy
Price Target: n/a
Current: $3.17
Upside: n/a
Feb 21, 2020
Rated: Hold
Price Target: n/a
Current: $3.74
Upside: n/a
Dec 31, 2019
Maintained: Hold
Price Target: n/a
Current: $5.49
Upside: n/a
Aug 12, 2019
Maintained: Hold
Price Target: n/a
Current: $40.36
Upside: n/a
Feb 25, 2016
Rated: Buy
Price Target: $497 → $345
Current: $206.75
Upside: n/a
Feb 25, 2016
Initiated Coverage: Buy
Price Target: $120 → $110
Current: $129.86
Upside: n/a
Sep 3, 2015
Initiated Coverage: Buy
Price Target: $266 → $94
Current: $7.77
Upside: n/a
Feb 18, 2015
Maintained: Hold
Price Target: $137 → $132
Current: $33.33
Upside: n/a
Nov 10, 2014
Initiated Coverage: Buy
Price Target: $37
Current: $7.99
Upside: n/a
Apr 22, 2014
Upgraded: Hold
Price Target: n/a
Current: $15.34
Upside: n/a
Jun 4, 2013
Maintained: Hold
Price Target: $7 → $5
Current: $37.68
Upside: n/a
Apr 19, 2013
Maintained: Buy
Price Target: $63 → $100
Current: $474.41
Upside: n/a
Mar 12, 2012
Downgraded: Hold
Price Target: $3
Current: $0.0001
Upside: n/a
Nov 17, 2010
Downgraded: Hold
Price Target: n/a
Current: $52.06
Upside: n/a